EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOY) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

EssilorLuxottica Unsponsored ADR (OTCMKTS:ESLOYGet Free Report) has received a consensus recommendation of “Moderate Buy” from the nine research firms that are presently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, two have assigned a hold recommendation, four have issued a buy recommendation and two have issued a strong buy recommendation on the company.

ESLOY has been the subject of a number of analyst reports. Deutsche Bank Aktiengesellschaft assumed coverage on EssilorLuxottica in a research note on Tuesday, May 12th. They set a “hold” rating for the company. The Goldman Sachs Group lowered shares of EssilorLuxottica from a “buy” rating to a “hold” rating in a report on Tuesday, July 14th. Finally, Zacks Research cut shares of EssilorLuxottica from a “hold” rating to a “strong sell” rating in a research report on Tuesday, June 23rd.

Check Out Our Latest Stock Analysis on ESLOY

EssilorLuxottica Stock Up 0.7%

ESLOY opened at $92.54 on Friday. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.70 and a current ratio of 0.99. The stock’s 50 day simple moving average is $98.99 and its 200 day simple moving average is $119.42. EssilorLuxottica has a 1 year low of $91.44 and a 1 year high of $186.81.

About EssilorLuxottica

(Get Free Report)

EssilorLuxottica SE is a global ophthalmic optics company formed through the 2018 merger of France-based Essilor and Italy-based Luxottica. Headquartered near Paris, the company combines lens manufacturing, frame design and production, brand management and retail operations to provide a vertically integrated offering across the vision care value chain. Its activities span product research and development, manufacturing, wholesale distribution and retailing of spectacles, sunglasses and ophthalmic lenses.

The company’s product portfolio includes prescription and non-prescription lenses, lens coatings and treatments, and an array of eyewear brands and frames.

Further Reading

Analyst Recommendations for EssilorLuxottica (OTCMKTS:ESLOY)

Receive News & Ratings for EssilorLuxottica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EssilorLuxottica and related companies with MarketBeat.com's FREE daily email newsletter.